Skip to main content
Premium Trial:

Request an Annual Quote

Chugai Licenses Genedata's Software

NEW YORK (GenomeWeb News) – Tokyo-based Chugai Pharmaceutical has signed a multi-year license agreement with Genedata for the use of its biomarker discovery software in R&D programs, the Swiss bioinformatics company said today.

Genedata said that Chugai has already been using the Expressionist software to normalize its microarray data pool, to standardize its microarray quality control process, and to obtain data for analysis.

Using the software to handle data from "tens of thousands" of data sets, Chugai's bioinformatics team member Junichi Muroya said in a statement, has "increased processing speed, facilitated sophisticated statistical analysis and overall improved the quality of our results significantly."

Financial terms of the agreement were not released.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.